Cancer is the most common cause of death worldwide. Among all cancer, lung cancer is the most commonly diagnosed cancer and the leading cause of cancer death. Algrofin is a low cost generic of Crizotinib, (DB08865) which is a tyrosine kinase inhibitor (TKI) for the patient with advanced metastatic non-small cell lung cancer (NSCLC) that have a certain abnormal anaplastic-lymphoma kinase (ALK)-positive gene mutation that has either spread to other parts of their body or not, and who have taken the medicine or chemotherapy before. Algrofin (Crizotinib), (DB08865) is also treatment option for patient with ROS1 positive in tumor specimen advanced non-small cell lung cancer(NSCLC). This generic of Xalkori is manufactured by Genvio Pharma Limited, a renowned pharmaceutical company in Bangladesh manufacturing anti-cancer generics in affordable price by maintaining highest quality followed by cGMP guideline. Lung cancer has become one of the most prevalent cancer worldwide. Hence, Genvio Pharma Limited is committed to manufacture quality medicine to fight abnormal anaplastic-lymphoma kinase (ALK) Positive and ROS1 positive lung cancer and convey it to the patient at a very affordable price. Algrofin (Crizotinib, DB08865) 250 mg capsule is available in 28’s pack. Therefore, Xalkori generics should be administered orally and can be taken with or without food, dosing 250 mg twice daily. Thus each box contains patient medication information’s so before starting medication please go through the leaflet or download from Algrofin (Crizotinib, generic of Xalkori) website ( The most common side effects of Algrofin (Generic of Xalkori) can be vision disorders, nausea, diarrhea, vomiting, edema, constipation, elevated transaminases, fatigue, decreased appetite, upper respiratory infection, dizziness, and neuropathy. Genvio Pharma Limited takes pride in manufacturing quality medicine by adhering to the current Good Manufacturing Practice (cGMP) to meet the international standard. Being one of the top anti-cancer medicine manufacturers in Bangladesh, Genvio Pharma is committed to manufacture better alternatives of research molecules at an affordable price. So Genvio keeps the cost of Xalkori generic, Algrofin comparatively lower than the cost of Xalkori for the patient who cannot afford Xalkori (Pfizer) treatment.

Recommended Daily Dose:

Recommended daily dose is 250mg Capsule twice daily, with or without food otherwise as directed by physician.